100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder |Complete Study Guide|Grade A+. $17.99   Add to cart
Quickly navigate to
Preview
  2.  
  3. Pharmacology And The Nursing Process 9th Editio
  4.  
  5. Pharmacology And The Nursing Process 9th Editio

Exam (elaborations)

Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder |Complete Study Guide|Grade A+.
 6 views  0 purchase
  • Course
  • Pharmacology And The Nursing Process 9th Editio
  • Institution
  • Pharmacology And The Nursing Process 9th Editio

Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder |Complete Study Guide|Grade A+.Test Bank for Pharmacology and the Nursing Process 9th Edition Linda Lilley Shelly Collins Julie Snyder |Complete Study Guide|Grade A+.Test Bank for Pharmacology an...

[Show more]

Preview 4 out of 582  pages

Document information

  • October 2, 2024
  • 582
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers

Subjects

  • test bank for pharmacology and the nursing process
  • pharmacology and the nursing process 9th edition

Connected book

book image

Book Title:

Author(s):

  • Edition:
  • ISBN:
  • Edition:

More summaries for

All for this textbook (283)

Written for

  • Pharmacology And The Nursing Process 9th Editio
  • Pharmacology And The Nursing Process 9th Editio

Seller

avatar-seller
Wisdoms

Reviews received

Content preview

,Chapter 01: The Nursing Process and Drug Therapy......................................................................................... 7
I;, I;, I;, I;, I;, I;, I;,




Chapter 02: Pharmacologic Principles ............................................................................................................. 14
I;, I;, I;,




Chapter 03: Lifespan Considerations ............................................................................................................... 24
I;, I;, I;,




Chapter 04: Cultural, Legal, and Ethical Considerations................................................................................... 35
I;, I;, I;, I;, I;, I;,




Chapter 05: Medication Errors: Preventing and Responding .......................................................................... 45
I;, I;, I;, I;, I;, I;,




Chapter 06: Patient Education and Drug Therapy ........................................................................................... 50
I;, I;, I;, I;, I;, I;,




Chapter 07: Over-the-Counter Drugs and Herbal and DietarySupplements ................................................ 58
I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 08: Gene Therapy and Pharmacogenomics ....................................................................................... 64
I;, I;, I;, I;, I;,




Chapter 09: Photo Atlas of Drug Administration ............................................................................................ 68
I;, I;, I;, I;, I;, I;,




Chapter 10: Analgesic Drugs ........................................................................................................................... 85
I;, I;, I;,




Chapter 11: General and Local Anesthetics .................................................................................................... 97
I;, I;, I;, I;, I;,




Chapter 12: Central Nervous System Depressants and Muscle Relaxants .................................................... 105
I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 13: Central Nervous System Stimulants and Related Drugs ............................................................. 115
I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 14: Antiepileptic Drugs .................................................................................................................... 121
I;, I;, I;,




Chapter 15: Antiparkinson Drugs .................................................................................................................. 132
I;, I;, I;,




Chapter 16: Psychotherapeutic Drugs ........................................................................................................... 142
I;, I;, I;,




Chapter 17: Substance Use Disorder............................................................................................................. 156
I;, I;, I;, I;,




Chapter 18: Adrenergic Drugs....................................................................................................................... 162
I;, I;, I;,




Chapter 19: Adrenergic-Blocking Drugs .......................................................................................................... 10
I;, I;, I;,




Chapter 20: Cholinergic Drugs....................................................................................................................... 116
I;, I;, I;,




Chapter 21: Cholinergic-Blocking Drugs .......................................................................................................... 11
I;, I;, I;,




Chapter 22: Antihypertensive Drugs ............................................................................................................. 126
I;, I;, I;,




Chapter 23: Antianginal Drugs ........................................................................................................................ 11
I;, I;, I;,




Chapter 24: Heart Failure Drugs.................................................................................................................... 129
I;, I;, I;, I;,




Chapter 25: Antidysrhythmic Drugs .............................................................................................................. 142
I;, I;, I;,




Chapter 26: Coagulation Modifier Drugs ....................................................................................................... 154
I;, I;, I;, I;,




Chapter 27: Antilipemic Drugs ...................................................................................................................... 166
I;, I;, I;,




Chapter 28: Diuretic Drugs ........................................................................................................................... 175
I;, I;, I;,




Chapter 29: Fluids and Electrolytes ............................................................................................................... 187
I;, I;, I;, I;,




Chapter 30: Pituitary Drugs ........................................................................................................................... 197
I;, I;, I;,




Chapter 31: Thyroid and Antithyroid Drugs .................................................................................................. 202
I;, I;, I;, I;, I;,




Chapter 32: Antidiabetic Drugs ..................................................................................................................... 210
I;, I;, I;,




Chapter 33: Adrenal Drugs ........................................................................................................................... 229
I;, I;, I;,

,Chapter 34: Women’s Health Drugs ............................................................................................................. 236
I;, I;, I;, I;,




Chapter 35: Men’s Health Drugs ................................................................................................................... 249
I;, I;, I;, I;,




Chapter 36: Antihistamines, Decongestants, Antitussives, andExpectorants ............................................ 259
I;, I;, I;, I;, I;, I;,




Chapter 37: Respiratory Drugs ...................................................................................................................... 270
I;, I;, I;,




Chapter 38: Antibiotics Part 1 ...................................................................................................................... 280
I;, I;, I;, I;,




Chapter 39: Antibiotics Part 2....................................................................................................................... 294
I;, I;, I;, I;,




Chapter 40: Antiviral Drugs ........................................................................................................................... 303
I;, I;, I;,




Chapter 41: Antitubercular Drugs ................................................................................................................. 313
I;, I;, I;,




Chapter 42: Antifungal Drugs ....................................................................................................................... 321
I;, I;, I;,




Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ................................................................... 24
I;, I;, I;, I;, I;, I;,




Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and CellCycle–Specific Drugs ........................... 270
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugsand Miscellaneous Drugs ........... 283
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,




Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs............................................................ 292
I;, I;, I;, I;, I;, I;,




Chapter 48: Immunosuppressant Drugs........................................................................................................ 301
I;, I;, I;,




Chapter 49: Immunizing Drugs ..................................................................................................................... 311
I;, I;, I;,




Chapter 50: Acid-Controlling Drugs............................................................................................................... 320
I;, I;, I;,




Chapter 51: Bowel Disorder Drugs ................................................................................................................ 333
I;, I;, I;, I;,




Chapter 52: Antiemetic and Antinausea Drugs ............................................................................................. 348
I;, I;, I;, I;, I;,




Chapter 53: Vitamins and Minerals ............................................................................................................... 358
I;, I;, I;, I;,




Chapter 54: Anemia Drugs ............................................................................................................................ 369
I;, I;, I;,




Chapter 55: Nutritional Supplements ............................................................................................................ 382
I;, I;, I;,




Chapter 56: Dermatologic Drugs................................................................................................................... 389
I;, I;, I;,




Chapter 57: Ophthalmic Drugs ...................................................................................................................... 402
I;, I;, I;,




Chapter 58: Otic Drugs .................................................................................................................................. 410
I;, I;, I;,

, Chapter 01: The Nursing Process and Drug Therapy I;, I;, I;, I;, I;, I;, I;,




MULTIPLE CHOICE I;,




1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



newlydiagnosed with type 2 diabetes. Which statement reflects the correct format for a
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



nursing diagnosis?
I;, I;,



a. Anxiety
b. Anxietyrelated to new drug therapy I;, I;, I;, I;, I;,



c. Anxietyrelated to anxious feelings about drug therapy, as evidenced by I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



statementssuch as ―I‘m upset about having to test my blood sugars.‖
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



d. Anxietyrelated to new drug therapy, as evidenced by statements such as ―I‘m
I;, I;, I;, I;, I;, I;, I;, I; , I;, I;, I;, I;,



upset about having to test my blood sugars.‖
I;, I;, I;, I;, I;, I;, I;, I;,




ANS: D I;,



Formulation of nursing diagnoses is usually a three-step process. ―Anxiety‖ is missing the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



―related to‖ and ―as evidenced by‖ portions of defining characteristics. ―Anxiety related to new
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



drug therapy‖ is missing the ―as evidenced by‖ portion of defining characteristics. The
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



statementbeginning ―Anxiety related to anxious feelings‖ is incorrect because the ―related to‖
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



section is simply a restatement of the problem ―anxiety,‖ not a separate factor related to the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



response.
I;,




DIF: COGNITIVE LEVEL: Understanding I;, I;,



(Comprehension)TOP: NURSING PROCESS: Nursing
I;, I;, I ; , I;, I;,



Diagnosis
I;,



MSC: NCLEX: Safe and Effective Care Environment: Management of Care
I ; , I;, I;, I;, I;, I;, I;, I;, I;,




2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse was busy
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



andgave the medication 2 hours after the scheduled dose was due. What type of problem does
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



this represent?
I;, I;,



a. ―Right time‖ I;,



b. ―Right dose‖ I;,



c. ―Right route‖ I;,



d. ―Right medication‖ I;,




ANS: A I;,



―Right time‖ is correct because the medication was given more than 30 minutes after the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



scheduled dose was due. ―Dose‖ is incorrect because the dose is not related to the time the
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



medication administration is scheduled. ―Route‖ is incorrect because the route is not affected.
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



―Medication‖ is incorrect because the medication ordered will not change. I;, I;, I;, I;, I;, I; , I;, I;, I;,




DIF: COGNITIVE LEVEL: Applying I;, I;,



(Application)TOP: NURSING PROCESS:
I;, I;, I ; , I;,



Implementation
I;,



MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
I ; , I;, I;, I;, I;, I;, I;, I;, I;, I;,




3. The nurse has been monitoring the patient‘s progress on a new drug regimen since the first
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,



I;, doseand documenting the patient‘s therapeutic response to the medication. Which phase of
I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;, I;,

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Wisdoms. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $17.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

72042 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$17.99
  • (0)
  Add to cart